A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression
A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression
Objective
We hypothesized that combining antidepressant medication with a standardized telephone adherence support intervention would lead to superior outcomes in the treatment of depression compared with antidepressant medication alone.
Method
Patients with depression were randomized to receive the antidepressant duloxetine alone (DLX), or duloxetine plus a standardized telephone intervention (DLX + TI), for 12 weeks of open-label treatment. The primary outcome measure was remission (HAMD17 total score ? 7) at study endpoint. Safety and tolerability were assessed via reporting of treatment-emergent adverse events (AEs), vital signs and laboratory measures. The TI was delivered approximately 1, 4, and 9 weeks after initiation of duloxetine.
Results
The DLX (N = 485) and DLX + TI (N = 477) groups did not differ significantly at baseline. At study endpoint, remission rates (42.8% vs. 43.5%, P = 0.87), response rates (56.6% vs. 58.4%, P = 0.58) and other secondary outcomes were similar between the groups. A similar proportion of patients in each group completed the study, and adverse event discontinuation rates were not significantly different (10.7% vs. 13.0%, P = 0.318). More AEs were reported by patients in the DLX + TI group, however, and constipation (3.5% vs. 10.1%, P < 0.001) and hot flush (0.2% vs. 1.7%, P = 0.020) were reported by more DLX + TI patients. Adherence to medication was high (> 90% at every visit) in both groups.
Conclusions
A telephone intervention in combination with antidepressant medication (duloxetine) did not improve depression outcomes compared with antidepressant alone in this clinical trial, perhaps due to high drug adherence in both treatment groups. Addition of a telephone intervention was, however, associated with increased reporting of AEs.
duloxetine, major depressive disorder, telephone intervention, adherence
33-41
Perahia, David G.S.
5fd14550-cc63-417e-9bf5-69ef2c17e3b6
Quail, Deborah
92750eb7-8c18-44ad-a800-ae6830cd1a1e
Gandhi, Paul
e63eb0bf-2a69-49e3-a989-e09ee4d221a4
Walker, Daniel J.
46f91ff9-ef1d-482a-8a7e-7706515b20c8
Peveler, Robert C.
93198224-78d9-4c1f-9c07-fdecfa69cf96
May 2008
Perahia, David G.S.
5fd14550-cc63-417e-9bf5-69ef2c17e3b6
Quail, Deborah
92750eb7-8c18-44ad-a800-ae6830cd1a1e
Gandhi, Paul
e63eb0bf-2a69-49e3-a989-e09ee4d221a4
Walker, Daniel J.
46f91ff9-ef1d-482a-8a7e-7706515b20c8
Peveler, Robert C.
93198224-78d9-4c1f-9c07-fdecfa69cf96
Perahia, David G.S., Quail, Deborah, Gandhi, Paul, Walker, Daniel J. and Peveler, Robert C.
(2008)
A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.
Journal of Affective Disorders, 108 (1-2), .
(doi:10.1016/j.jad.2007.08.023).
Abstract
Objective
We hypothesized that combining antidepressant medication with a standardized telephone adherence support intervention would lead to superior outcomes in the treatment of depression compared with antidepressant medication alone.
Method
Patients with depression were randomized to receive the antidepressant duloxetine alone (DLX), or duloxetine plus a standardized telephone intervention (DLX + TI), for 12 weeks of open-label treatment. The primary outcome measure was remission (HAMD17 total score ? 7) at study endpoint. Safety and tolerability were assessed via reporting of treatment-emergent adverse events (AEs), vital signs and laboratory measures. The TI was delivered approximately 1, 4, and 9 weeks after initiation of duloxetine.
Results
The DLX (N = 485) and DLX + TI (N = 477) groups did not differ significantly at baseline. At study endpoint, remission rates (42.8% vs. 43.5%, P = 0.87), response rates (56.6% vs. 58.4%, P = 0.58) and other secondary outcomes were similar between the groups. A similar proportion of patients in each group completed the study, and adverse event discontinuation rates were not significantly different (10.7% vs. 13.0%, P = 0.318). More AEs were reported by patients in the DLX + TI group, however, and constipation (3.5% vs. 10.1%, P < 0.001) and hot flush (0.2% vs. 1.7%, P = 0.020) were reported by more DLX + TI patients. Adherence to medication was high (> 90% at every visit) in both groups.
Conclusions
A telephone intervention in combination with antidepressant medication (duloxetine) did not improve depression outcomes compared with antidepressant alone in this clinical trial, perhaps due to high drug adherence in both treatment groups. Addition of a telephone intervention was, however, associated with increased reporting of AEs.
This record has no associated files available for download.
More information
e-pub ahead of print date: 10 October 2007
Published date: May 2008
Keywords:
duloxetine, major depressive disorder, telephone intervention, adherence
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 62534
URI: http://eprints.soton.ac.uk/id/eprint/62534
ISSN: 0165-0327
PURE UUID: 7e9330f7-7cb1-4bd2-861e-bbcb88f2187a
Catalogue record
Date deposited: 06 Apr 2009
Last modified: 16 Mar 2024 02:38
Export record
Altmetrics
Contributors
Author:
David G.S. Perahia
Author:
Deborah Quail
Author:
Paul Gandhi
Author:
Daniel J. Walker
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics